De Novo closes $300m health tech fund
The California venture capital firm closed its third fund on $300m, to be used for investments in the medical technology and biotechnology sectors.
The California venture capital firm closed its third fund on $300m, to be used for investments in the medical technology and biotechnology sectors.
Copyright PEI Media
Not for publication, email or dissemination